Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...
Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback